8:00 am Registration & Networking Coffee

Overcoming Challenges in Preclinical Assessment & Translation to Accelerate Product Development

9:20 am Chair’s Opening Remarks

9:30 am Challenges in Medical Cannabis Research & Translation to Clinical Practice

Determining the Mechanisms Involved in the Endocannabinoid System and Cannabinoid Receptor Biology

10:00 am Plant-Derived & Endogenous Cannabinoids: Naturally Different

  • Mauro Maccarrone Professor & Chair of Biochemistry and Molecular Biology, University of Rome

10:30 am Peripherally Restricted CB1 Receptor Blockers for the Treatment of the Metabolic Syndrome

  • Simon Benita Professor & Chairman, Hebrew University of Jerusalem, BioNanoSim Ltd

11:00 am Speed Networking Break

11:30 am Understanding the Endocannabinoid System and Cannabinoid Receptor Biology

12:00 pm Panel Discussion: Comparing Whole Plant & Synthetic Cannabinoids & Their Potential in Pharmaceuticals

12:30 pm Lunch & Networking Break

Overcoming the Regulatory Hurdles to Gain Approval From Governing Bodies

1:00 pm Roundtable Discussion: Bringing Regulations Up to Date Across the World


This interactive session will require delegates to discuss creative solutions to old problems. Through
interactive discussion delegates will fill out a worksheet containing questions related to the regulation and
disparities between the US and EU. Here we will highlight and illustrate the problems that currently exist in
the system and come up with an idea, process or other solution that could fix this issue

2:00 pm Rx & Non-Rx Cannabinoids: A Regulatory Framework for Market Access & Product Quality in Healthcare & Selfcare

2:30 pm Panel Discussion: The Industry Approach to Gaining Drug Approval

3:00 pm Networking Break

3:30 pm Panel Discussion: What Targets are Optimal for Different Disease Indications

4:00 pm Comparing Whole Plant and Synthetic


·       Cost advantages short term & long term

·       Not all cannabinoids are available in the plant

·       What the consumer wants and needs.

4:30 pm Chair’s Closing Remarks & End of Day One